Response
‘Slamming’ among men who have sex with men accessing general drug services, in response to Schmidt, AJ et al., 2016, Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS)

https://doi.org/10.1016/j.drugpo.2017.07.028Get rights and content

References (7)

There are more references available in the full text version of this article.

Cited by (12)

  • Correlates and subgroups of injecting drug use in UK gay and bisexual men: Findings from the 2014 Gay Men's Sex Survey

    2018, Drug and Alcohol Dependence
    Citation Excerpt :

    Major cross-sectional surveys of drug use by GBM have not been able to recruit enough GBM who inject drugs for comparison (Sewell et al., 2017). Data from the Unlinked and Anonymous Monitoring survey of people who inject drugs compared GBM and non-GBM among men who inject drugs and found that GBM were more likely to have recently begun injecting and to engage in high-risk sexual practices; however, this survey was unable to describe patterns within GBM who inject drugs (Glass et al., 2017). Not all injection drug use may be related to sex, and different profiles of injection drug use may exist among GBM.

  • Sexualised drug use in the United Kingdom (UK): A review of the literature

    2018, International Journal of Drug Policy
    Citation Excerpt :

    National monitoring at general drug services through the UAM Survey of PWID found the injection of mephedrone and ketamine in the last month to be 12% and 6% respectively among MSM attendees during 2013–2016, which was higher than the injected use of mephedrone and ketamine among non-MSM attendees (5% and 2%) (Heinsbroek, Glass, Edmundson, Hope, & Desai, 2018). Since 2000, an increase in the proportion of males recruited in the survey who reported sex with men has been observed (4.4% in 2000/01 to 8.4% in 2014/15), as well as altered drug use patterns with increasing stimulant injection and decreasing opiate injection among MSM, suggesting ‘slamming’ is now evident among MSM accessing general drug services (Glass, Hope, Tanner, & Desai, 2017). Nationally, subgroups of MSM are participating in Chemsex and SDU, potentially heightening their risk of STI or BBV acquisition and other health harms.

  • Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013–2016

    2018, International Journal of Drug Policy
    Citation Excerpt :

    Injecting drug use in England, Wales and Northern Ireland is monitored by the unlinked anonymous monitoring (UAM) survey of people who inject drugs, which samples from a range of generic drug services (including needle and syringe programmes (NSPs) and drug and alcohol treatment services). Since 2000, the proportion of all male PWID recruited in the UAM survey who reported sex with men has increased from 4% in 2000/01 to 8% in 2014/15 (Glass, Hope, Tanner, & Desai, 2017). MSM were more often recent initiates to injecting as compared to heterosexual men (13% vs. 8%) (Glass et al., 2017).

  • Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey

    2018, International Journal of Drug Policy
    Citation Excerpt :

    Injection history was associated with approximately five times higher odds of party drug use and almost six times higher odds of chemsex drugs use. As noted by Glass et al. (Glass, Hope, Tanner, & Desai, 2017) injecting drugs associated with sexualised drug use (‘slamming’) may be on the increase. Although we did not collect information on whether or not injecting took place in the context of sexual encounters, we note that at least the subgroups of MSM who inject drugs and MSM who practice chemsex overlap.

View all citing articles on Scopus
View full text